New research from the University of Adelaide and SAHMRI has uncovered a potential new treatment for multiple myeloma that inhibits tumour growth and could have the potential to delay or even prevent relapse.
A groundbreaking leukaemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR) – meaning they are effectively cured of the disease.
Researchers from the University of Adelaide will collaborate with European researchers to better understand and manage treatment resistance for mental health disorders such as depression, bipolar disorder and schizophrenia.
Scientists from the University of Adelaide’s Research Centre for Infectious Diseases have identified a key protein that controls malaria parasite entry into host red blood cells.
An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia (CML).